CIK: 0001839209 · Show all filings
Period: Q4 2022 (← Previous) (Next →)
Filing Date: Feb 14, 2023
Total Value ($000): $160,625 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| ARGX | ARGENX SE | 297,701 | $112,778 | 70.2% | $378.83 | — | SPONSORED ADR | 04016X101 |
| KROS | KEROS THERAPEUTICS INC | 428,532 | $20,578 | 12.8% | $46.71 | 0.0% | COM | 492327101 |
| — | AMBRX BIOPHARMA INC | 7,584,489 | $17,217 | 10.7% | $2.27 | — | SPONSORED ADS | 02290A102 |
| — | PROMETHEUS BIOSCIENCES INC | 91,379 | $10,052 | 6.3% | $110.00 | — | COM | 74349U108 |